<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>4 patients below the age of 20 years have been treated for a <z:e sem="disease" ids="C1140680" disease_type="Neoplastic Process" abbrv="">malignant tumor of the ovary</z:e> during the period November 1, 1984 until April 30, 1988 </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0100621'>Dysgerminoma</z:hpo> was the diagnosis in two cases, as the third patient suffered from a bilateral malignant <z:hpo ids='HP_0009792'>teratoma</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Burkitt's <z:hpo ids='HP_0002665'>Lymphoma</z:hpo> involved both ovaries primarily in an 17-year-old girl </plain></SENT>
<SENT sid="3" pm="."><plain>Retrospectively we analyzed diagnosis, therapy and clinical course of these young patients </plain></SENT>
<SENT sid="4" pm="."><plain>Regarding the different histological types of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> that have been found we discuss critically current recommendations in therapeutic managements referring chemotherapy and/or radiotherapy </plain></SENT>
<SENT sid="5" pm="."><plain>Defined conditions provided surgical treatment, that preserves fertility in early stages of malignant <z:mpath ids='MPATH_310'>germ cell tumors</z:mpath> of adolescent women, may be justified, especially for <z:hpo ids='HP_0100621'>dysgerminomas</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>A real benefit relate to survival and quality of life by using chemotherapeutic agents can only be expected, if <z:hpo ids='HP_0000001'>all</z:hpo> prognostic factors are regarded </plain></SENT>
</text></document>